SHC calls off RTO, faces delisting if new business not found
SHC Capital faces potential delisting again after calling off a reverse takeover deal with Chinese equipment maker Tong Da Medical Device.
SHC, a cash company that was previously involved in underwriting insurance risks, said it could not make significant progress with Tong Da and its owners in carrying out a financial audit and other due diligence of the Chinese company.
Both parties agreed to terminate the deal as of Oct 31, SHC said. The company has spent about S$1.4 million so far on the terminated deal.
SHC has until Jan 31, 2016 to find a new business, or it will be delisted from the Catalist board.
The company said it is exploring options, including a voluntary liquidation if SHC cannot obtain a further extension of time to find a new business. If there is a voluntary liquidation, the company may make a distribution via a capital reduction or an interim distribution.
The company reported on Monday that it had S$38.9 million of net assets as at Oct 31, including S$39.3 million of cash and bank balances.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
SHC shares were not traded on Monday, but were bid at 12.9 Singapore cents and offered at 13.3 Singapore cents.
Share with us your feedback on BT's products and services
TRENDING NOW
Gojek founder Nadiem Makarim faces 18-year jail demand in Indonesia laptop graft trial
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
H&M lays off staff in Singapore, moves regional headquarters to Malaysia
Singapore developer in limbo after Timor-Leste scraps major township project